Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atezolizumab combinations in HR+ HER2- breast cancer
NCT03280563Phase 2Completed
- Sponsor
- Roche
- Start
- Dec 2017
- Primary completion
- Sep 2024
- Modality
- Monoclonal Antibodies
- Countries
- 3
01
Overview
A Phase 2 trial of atezolizumab in breast cancer, sponsored by Roche. Started Dec 2017; status: completed.
02
Drugs
atezolizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT03280563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03280563.